Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN15119574
ISRCTN15119574
Completed
Phase 2

Melatonin as a novel neuroprotectant in preterm infants - trial study

Imperial College London (UK)0 sites60 target enrollmentJanuary 6, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBrain injury in premature babiesNeonatal DiseasesUnspecified brain damage due to birth injury

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Brain injury in premature babies
Sponsor
Imperial College London (UK)
Enrollment
60
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 6, 2012
End Date
July 1, 2014
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Imperial College London (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Infants born less than 31 weeks gestation who are less than 48 hours old
  • •2\. Parental consent for participation has been given

Exclusion Criteria

  • •1\. Those with major congenital malformation
  • •2\. Those with cystic periventricular leucomalacia (cPVL)
  • •3\. Those with haemorrhagic parenchymal infarcts (HPI) on cranial ultrasonography prior to enrolment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
MIND: Melatonin Neuroprotection Dosage StudyTopic: Medicines for Children Research NetworkSubtopic: All DiagnosesDisease: All DiseasesInjury, Occupational Diseases, PoisoningBrain injury
ISRCTN01115788Imperial College London (UK)24
Active, not recruiting
Phase 1
Melatonin As A Novel Neuroprotectant in Preterm Infants- Dosage study - MIND-Melatonin Neuroprotection Dosage Study
EUCTR2007-007156-33-GBImperial College18
Active, not recruiting
Phase 1
Melatonin As A Novel Neuroprotectant In Preterm Infants-Trial Study - MINT- Melatonin Neuroprotection Trial Study -Ver 1Brain injury from prematurityMedDRA version: 14.0 Level: LLT Classification code 10013384 Term: Disorders relating to short gestation and unspecified low birthweight System Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditions
EUCTR2008-004740-36-GBImperial College, London60
Completed
Phase 2
Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage StudyPremature BirthBrain Injury
NCT00649961Imperial College London18
Completed
Not Applicable
Oral Melatonin as Neuroprotectant in Preterm InfantsMalondialdehydeMelatonin
NCT04235673Francesca Garofoli60